Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for many people with Type 1 diabetes. Little attention has been paid to how individuals self-treat hypoglycaemia and their likes and dislikes of clinically recommended treatments. We explored participants' experiences of self-treating hypoglycaemia after attending a structured education programme for people with Type 1 diabetes. Our aims were: to identify treatments that are acceptable to people with Type 1 diabetes; and to provide recommendations for promoting self-treatment in line with clinical guidelines. Methods: Thirty adults with Type 1 diabetes were recruited from the Dose Adjustment for Normal Eating (DAFNE) programme in the UK. Study ...
Almost 100 years since the discovery of insulin, hypoglycaemia remains a barrier for people with typ...
Aim: To further our understanding of individual use and experience of continuous glucose monitoring ...
Aim: Hypoglycaemia may have a detrimental impact on quality of life for patients with Type2 diabetes...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Impaired awareness of hypoglycaemia (IAH) is a major risk for severe hypoglycaemia in insulin treatm...
Hypoglycaemia is a feared complication of insulin-treated diabetes. Treatment recommendations vary w...
Objective Risk of severe hypoglycaemia is increased by absence of subjective awareness of hypoglycae...
Almost 100 years since the discovery of insulin, hypoglycaemia remains a barrier for people with typ...
Aim: To further our understanding of individual use and experience of continuous glucose monitoring ...
Aim: Hypoglycaemia may have a detrimental impact on quality of life for patients with Type2 diabetes...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Impaired awareness of hypoglycaemia (IAH) is a major risk for severe hypoglycaemia in insulin treatm...
Hypoglycaemia is a feared complication of insulin-treated diabetes. Treatment recommendations vary w...
Objective Risk of severe hypoglycaemia is increased by absence of subjective awareness of hypoglycae...
Almost 100 years since the discovery of insulin, hypoglycaemia remains a barrier for people with typ...
Aim: To further our understanding of individual use and experience of continuous glucose monitoring ...
Aim: Hypoglycaemia may have a detrimental impact on quality of life for patients with Type2 diabetes...